<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03705754</url>
  </required_header>
  <id_info>
    <org_study_id>2019/CCT</org_study_id>
    <nct_id>NCT03705754</nct_id>
  </id_info>
  <brief_title>Carbon Black Tattoo in Colon Cancer</brief_title>
  <official_title>EFFECT OF ENDOSCOPIC TATTOOING WITH CARBON BLACK SUSPENSION ON THE STAGING OF COLON CANCER</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Szeged University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Szeged University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to elucidate whether carbon black suspension endoscopic tattoo enhances
      visibility of lymph nodes or tumor tissue on dissection of colonic surgical specimen, thereby
      making improvement in staging defined as better pTNM stage via better visualisation of carbon
      marked metastatic or sentinel lymph nodes or marked primary tumor or adjacent tissues.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Other objectives are:

        -  to assess intraoperative visibility of carbon black tattoo in the tumor region and
           surrounding tissues

        -  to assess microscopic distribution of carbon ink in the layers of the colonic wall and
           adjacent tissues

        -  to assess complications related to carbon black tattoo procedure like microscopic
           fibrosis, micro- or macroscopic scarring, inflammatory reactions

        -  to assess long-term effects of ink injections on control endoscopies at 6 and 12 months

        -  to assess dissection time in tattooed-non tattooed lymphatic tissues
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 6, 2019</start_date>
  <completion_date type="Anticipated">February 6, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 6, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Tattoo arm vs. control arm</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of tumors visualised from peritoneal cavity/number of tattoos visualised form peritoneal cavity</measure>
    <time_frame>1 year</time_frame>
    <description>Distance in cm from tumor wich far carbon injection marked mucosa and adjacent tissues Number of inflammatory cells per field of view in injection site vs. non-injected mucosa Number of dissected total/normal/metastatic/carbon colored lymph nodes</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Endoscopic Tattoo of Suspected Colon Cancer</condition>
  <arm_group>
    <arm_group_label>Tattoo arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tattoo will be placed by endoscopic submucosal injection of carbon black suspension</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control arm</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Tattoo will not be placed but case will follow standard procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>carbon black suspension colonic tattoo injection</intervention_name>
    <description>Examine the SPOT syringe to verify that the pigment is fully suspended. A 23 or 25 G sclerotherapy needle is recommended for this procedure, attach the syringe and prime with SPOT. After injection catheter is primed, manoeuver with the endoscope for optimal injection position and inject tangentially, at a 30-40˚ angle to the mucosa and create a saline bleb to find the submucosal plane prior to injecting SPOT to reduce risk of intramural injection. Document both the depth of scope and anatomic location of each tattoo and the ink consumption as well. Place injection 2-3 cm distal (downstream) of the area of interest. Use 0.5-0.75 mL per injection site and no more than 8 mL per patient. Place SPOT tattoos in 3-4 quadrants around the lumen to increase likelihood of visualisation.</description>
    <arm_group_label>Tattoo arm</arm_group_label>
    <other_name>GI supply SPOT endoscopic marker</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female aged 18 years or above undergoing colonoscopy for suspected colonic
             malignancy

          -  Participant is able to give informed consent for participation in the study

          -  Patient is presumably selected for surgery within 30 days following tattoo injection

        Exclusion Criteria:

          -  Patients under the age of 18

          -  Patients unable to give informed consent or ineligible for surgery

          -  Tumor in the coecum dome or in the rectum (&lt;15 cm)

          -  Known allergy to suspension ingredients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matyas Czepan, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Szeged University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matyas Czepan, MD, PhD</last_name>
    <phone>+3662545189</phone>
    <email>czepan.matyas@med.u-szeged.hu</email>
  </overall_contact>
  <location>
    <facility>
      <name>1st Department of Medicine, University of Szeged</name>
      <address>
        <city>Szeged</city>
        <state>Csongrád</state>
        <zip>6720</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mátyás Czepán</last_name>
      <phone>+3662545189</phone>
      <email>czepanm@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <results_reference>
    <citation>Askin MP, Waye JD, Fiedler L, Harpaz N. Tattoo of colonic neoplasms in 113 patients with a new sterile carbon compound. Gastrointest Endosc. 2002 Sep;56(3):339-42.</citation>
    <PMID>12196769</PMID>
  </results_reference>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>October 8, 2018</study_first_submitted>
  <study_first_submitted_qc>October 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2018</study_first_posted>
  <last_update_submitted>March 9, 2019</last_update_submitted>
  <last_update_submitted_qc>March 9, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Szeged University</investigator_affiliation>
    <investigator_full_name>Matyas Czepan</investigator_full_name>
    <investigator_title>Head of Division of Internal Medicine 2/S</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

